• About
  • Privacy Policy
  • Terms Of Use
  • Contact
Saturday, May 24, 2025
Pharma Info Nepal
  • Home
  • Loksewa
  • License
  • Questions
  • Vacancy
  • Downloads
  • Notice
  • Pharmacy Books
  • Pharmacy Notes
No Result
View All Result
  • Home
  • Loksewa
  • License
  • Questions
  • Vacancy
  • Downloads
  • Notice
  • Pharmacy Books
  • Pharmacy Notes
No Result
View All Result
Pharma Info Nepal
No Result
View All Result
Home Updates

FDA Approved HIV Medicines

FDA Approved HIV Medicines

Nabin Bista by Nabin Bista
January 26, 2023
in Updates
0
FDA-Approved HIV Medicines
395
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

FDA Approved HIV Medicines

Treatment with HIV medicines is called antiretroviral therapy (ART). ART is recommended for everyone with HIV, and people with HIV should start ART as soon as possible. People on ART take a combination of HIV medicines (called an HIV treatment regimen) every day. A person’s initial HIV treatment regimen generally includes three HIV medicines from at least two different HIV drug classes.

The following table lists HIV medicines recommended for the treatment of HIV infection in the United States, based on the U.S. Department of Health and Human Services (HHS) HIV/AIDS medical practice guidelines. All of these drugs are approved by the U.S. Food and Drug Administration (FDA). The HIV medicines are listed according to drug class and identified by generic and brand names. Click on a drug name to view information on the drug from the Clinicalinfo Drug Database.

 

Drug Class Generic Name
(Other names and acronyms)
Brand Name FDA Approval Date
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
NRTIs block reverse transcriptase, an enzyme HIV needs to make copies of itself. abacavir
(abacavir sulfate, ABC)
Ziagen December 17, 1998
emtricitabine
(FTC)
Emtriva July 2, 2003
lamivudine
(3TC)
Epivir November 17, 1995
tenofovir disoproxil
fumarate

(tenofovir DF, TDF)
Viread October 26, 2001
zidovudine
(azidothymidine, AZT, ZDV)
Retrovir March 19, 1987
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
NNRTIs bind to and later alter reverse transcriptase, an enzyme HIV needs to make copies of itself. doravirine
(DOR)
Pifeltro August 30, 2018
efavirenz
(EFV)
Sustiva September 17, 1998
etravirine
(ETR)
Intelence January 18, 2008
nevirapine
(extended-release nevirapine, NVP)
Viramune June 21, 1996
Viramune XR (extended release) March 25, 2011
rilpivirine
(rilpivirine hydrochloride, RPV)
Edurant May 20, 2011
Protease Inhibitors (PIs)
PIs block HIV protease, an enzyme HIV needs to make copies of itself. atazanavir
(atazanavir sulfate, ATV)
Reyataz June 20, 2003
darunavir
(darunavir ethanolate, DRV)
Prezista June 23, 2006
fosamprenavir
(fosamprenavir calcium, FOS-APV, FPV)
Lexiva October 20, 2003
ritonavir
(RTV)
*Although ritonavir is a PI, it is generally used as a pharmacokinetic enhancer as recommended in the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV and the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection.
Norvir March 1, 1996
tipranavir
(TPV)
Aptivus June 22, 2005
Fusion Inhibitors
Fusion inhibitors block HIV from entering the CD4 T lymphocyte (CD4 cells) of the immune system. enfuvirtide
(T-20)
Fuzeon March 13, 2003
CCR5 Antagonists
CCR5 antagonists block CCR5 coreceptors on the surface of certain immune cells that HIV needs to enter the cells. maraviroc
(MVC)
Selzentry August 6, 2007
Integrase Strand Transfer Inhibitor (INSTIs)
Integrase inhibitors block HIV integrase, an enzyme HIV needs to make copies of itself. cabotegravir
(cabotegravir sodium, CAB)
Vocabria January 22, 2021
dolutegravir
(dolutegravir sodium, DTG)
Tivicay August 12, 2013
Tivicay PD June 12, 2020
raltegravir
(raltegravir potassium, RAL)
Isentress October 12, 2007
Isentress HD May 26, 2017
Attachment Inhibitors
Attachment inhibitors bind to the gp120 protein on the outer surface of HIV, preventing HIV from entering CD4 cells. fostemsavir
(fostemsavir tromethamine, FTR)
Rukobia July 2, 2020
Post-Attachment Inhibitors
Post-attachment inhibitors block CD4 receptors on the surface of certain immune cells that HIV needs to enter the cells. ibalizumab-uiyk
(Hu5A8, IBA, Ibalizumab, TMB-355, TNX-355)
Trogarzo March 6, 2018
Pharmacokinetic Enhancers
Pharmacokinetic enhancers are used in HIV treatment to increase the effectiveness of an HIV medicine included in an HIV treatment regimen. cobicistat
(COBI, c)
Tybost September 24, 2014
Combination HIV Medicines
Combination HIV medicines contain two or more HIV medicines from one or more drug classes. abacavir and lamivudine
(abacavir sulfate / lamivudine, ABC / 3TC)
Epzicom August 2, 2004
abacavir, dolutegravir, and lamivudine
(abacavir sulfate / dolutegravir sodium / lamivudine, ABC / DTG / 3TC)
Triumeq August 22, 2014
Triumeq PD March 30, 2022
abacavir, lamivudine, and zidovudine
(abacavir sulfate / lamivudine / zidovudine, ABC / 3TC / ZDV)
Trizivir November 14, 2000
atazanavir and cobicistat
(atazanavir sulfate / cobicistat, ATV / COBI)
Evotaz January 29, 2015
bictegravir, emtricitabine, and tenofovir alafenamide
(bictegravir sodium / emtricitabine / tenofovir alafenamide fumarate, BIC / FTC / TAF)
Biktarvy February 7, 2018
cabotegravir and rilpivirine
(CAB and RPV, CAB plus RPV, Cabenuva kit, cabotegravir extended-release injectable suspension and rilpivirine extended-release injectable suspension)
Cabenuva January 22, 2021
darunavir and cobicistat
(darunavir ethanolate / cobicistat, DRV / COBI)
Prezcobix January 29, 2015
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide
(darunavir ethanolate / cobicistat / emtricitabine / tenofovir AF, darunavir ethanolate / cobicistat / emtricitabine / tenofovir alafenamide, darunavir / cobicistat / emtricitabine / tenofovir AF, darunavir / cobicistat / emtricitabine / tenofovir alafenamide fumarate, DRV / COBI / FTC / TAF)
Symtuza July 17, 2018
dolutegravir and lamivudine
(dolutegravir sodium / lamivudine, DTG / 3TC)
Dovato April 8, 2019
dolutegravir and rilpivirine
(dolutegravir sodium / rilpivirine hydrochloride, DTG / RPV)
Juluca November 21, 2017
doravirine, lamivudine, and tenofovir disoproxil fumarate
(doravirine / lamivudine / TDF, doravirine / lamivudine / tenofovir DF, DOR / 3TC / TDF)
Delstrigo August 30, 2018
efavirenz, emtricitabine, and tenofovir disoproxil fumarate
(efavirenz / emtricitabine / tenofovir DF, EFV / FTC / TDF)
Atripla July 12, 2006
efavirenz, lamivudine, and tenofovir disoproxil fumarate
(EFV / 3TC / TDF)
Symfi March 22, 2018
efavirenz, lamivudine, and tenofovir disoproxil fumarate
(EFV / 3TC / TDF)
Symfi Lo February 5, 2018
elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide
(elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide fumarate, EVG / COBI / FTC / TAF)
Genvoya November 5, 2015
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate
(QUAD, EVG / COBI / FTC / TDF)
Stribild August 27, 2012
emtricitabine, rilpivirine, and tenofovir alafenamide
(emtricitabine / rilpivirine / tenofovir AF, emtricitabine / rilpivirine / tenofovir alafenamide fumarate, emtricitabine / rilpivirine hydrochloride / tenofovir AF, emtricitabine / rilpivirine hydrochloride / tenofovir alafenamide, emtricitabine / rilpivirine hydrochloride / tenofovir alafenamide fumarate, FTC / RPV / TAF)
Odefsey March 1, 2016
emtricitabine, rilpivirine, and tenofovir disoproxil fumarate
(emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate, emtricitabine / rilpivirine / tenofovir, FTC / RPV / TDF)
Complera August 10, 2011
emtricitabine and tenofovir alafenamide
(emtricitabine / tenofovir AF, emtricitabine / tenofovir alafenamide fumarate, FTC / TAF)
Descovy April 4, 2016
emtricitabine and tenofovir disoproxil fumarate
(emtricitabine / tenofovir DF, FTC / TDF)
Truvada August 2, 2004
lamivudine and tenofovir disoproxil fumarate
(3TC / TDF)
Cimduo February 28, 2018
lamivudine and zidovudine
(3TC / ZDV)
Combivir September 27, 1997
lopinavir and ritonavir
(ritonavir-boosted lopinavir, LPV/r, LPV / RTV)
Kaletra September 15, 2000

 

Source: https://hivinfo.nih.gov/understanding-hiv/fact-sheets/fda-approved-hiv-medicines



  • WHO Model List of Essential Medicines 22nd List (2021)
  • National List of Essential Medicines Nepal 2021
Tags: FDAMedicine Information
Previous Post

Combined Oral Contraceptives (COC)

Next Post

Vacancy Announcement Assistant Professor Pharmacy and Medicine Dispenser 

Nabin Bista

Nabin Bista

Hello, Thank You for visiting my blog I am Nabin Bista, Dedicated and self motivated young Registered Pharmacist from Nepal. Blogging is my passion. I did my B Pharmacy from Institute of Medicine - IOM, Currently working as Hospital Pharmacist at Patan Academy of Health Sciences (PAHS). If you want me to write about any posts that you found confusing/difficult, please mention in the comments below.

Related Posts

Best NPC License Preparation Classes in Nepal for Pharmacy Students
License

Best NPC License Preparation Classes in Nepal for Pharmacy Students

May 22, 2025
WHO-GMP Certified Domestic Drug Manufacturers in Nepal: Current Status and Future Outlook
Updates

WHO-GMP Certified Domestic Drug Manufacturers in Nepal: Current Status and Future Outlook

May 21, 2025
Maturity Level of National Regulatory Authority – DDA Nepal
Updates

Maturity Level of National Regulatory Authority – DDA Nepal

May 21, 2025
Understanding the Relationship Between BCS Classification and IVIVC
Pharmacy Notes

Understanding the Relationship Between BCS Classification and IVIVC: A Key to Smarter Drug Development

May 16, 2025
Top 40 Pharmaceutical Brands in Nepal
Updates

Top 40 Pharmaceutical Brands in Nepal

May 7, 2025
Vacancy Announcement R & D Nepal Pharmaceutical Laboratory
Updates

Vacancy Announcement R & D Nepal Pharmaceutical Laboratory

April 30, 2025
Load More
Next Post
Vacancy Announcement Assistant Professor Pharmacy and Medicine Dispenser 

Vacancy Announcement Assistant Professor Pharmacy and Medicine Dispenser 

Discussion about this post

Recommended

Vacancy Announcement for Pharmacy Lecturer Medicinal Chemistry and Pharmaceutical Analysis

Vacancy Announcement for Pharmacy Lecturer Medicinal Chemistry and Pharmaceutical Analysis

May 24, 2025
Pharmaceutical Calculations MCQs – 30 Questions with Answers

Pharmaceutical Calculations MCQs – 30 Questions with Answers

May 22, 2025
Vacancy Announcement at Simca Laboratories Pvt. Ltd

Vacancy Announcement at Simca Laboratories Pvt. Ltd

May 22, 2025
Best NPC License Preparation Classes in Nepal for Pharmacy Students

Best NPC License Preparation Classes in Nepal for Pharmacy Students

May 22, 2025
WHO-GMP Certified Domestic Drug Manufacturers in Nepal: Current Status and Future Outlook

WHO-GMP Certified Domestic Drug Manufacturers in Nepal: Current Status and Future Outlook

May 21, 2025
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram

About Pharma Info Nepal

Pharma Info Nepal is a dedicated platform led by Nabin Bista, focused on empowering pharmacy students and professionals in Nepal. We provide high-quality educational resources, exam preparation materials, and professional guidance for pharmacy licensure exams and beyond. Our mission is to uplift the pharmacy profession in Nepal by fostering knowledge, skills, and excellence in pharmaceutical practice.

Explore our services, stay updated on pharmacy trends, and join a community striving for innovation and professionalism in healthcare.

Important Information

All content available on this website, including text, images, files, and other resources, is strictly protected under applicable copyright and intellectual property laws. Any reuse, reproduction, or redistribution of materials without prior written permission from Pharma Info Nepal is prohibited and may result in legal action.

Pharma Info Nepal operates as a registered company dedicated to maintaining the authenticity and integrity of its content and services.

Thank you for respecting our policies and supporting our mission to advance pharmacy education and practice.

Categories

  • B Pharmacy
  • Colleges
  • D Pharmacy
  • Downloads
  • License
  • Loksewa
  • M Pharmacy
  • Medicinal Chemistry
  • Notice
  • Nursing
  • Pharmacognosy
  • Pharmacology
  • Pharmacy Notes
  • Questions
  • Scholarship
  • Study Materials
  • Syllabus
  • Updates
  • Vacancy

DOWNLOADS

Pharmacy Book 

Pharmacy Act and Guidelines

About Pharma Info Nepal

About Admin

  • About
  • Privacy Policy
  • Terms Of Use
  • Contact

© 2025 Pharma Info Nepal | All Rights Reserved

error:
No Result
View All Result
  • About Pharma Info Nepal 
  • Become an Instructor
  • Checkout
  • Contact
  • Courses
  • Home
  • Instructor
  • Instructors
  • Nabin Bista
  • Pharmacy Act and Guidelines
  • Pharmacy Books
  • Privacy Policy
  • Profile
  • Terms and Conditions
  • Terms Of Use

© 2025 Pharma Info Nepal | All Rights Reserved